Aminoglutethimide: Medical Adrenalectomy in the Management of Carcinoma of the Prostate. A Review after 6 Years

British Journal of Urology

Volumn 52, Issue 4, 1980, Pages 328-329

  ROBINSON, M R G ^a  

^a Pontefract General Infirmary   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; CORTISONE; DIETHYLSTILBESTROL;

ADRENALECTOMY; DRUG THERAPY; ENDOCRINE SYSTEM; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM; PROSTATE CARCINOMA; THERAPY;

ADRENAL GLANDS; AMINOGLUTETHIMIDE; DRUG EVALUATION; FOLLOW-UP STUDIES; HUMAN; MALE; PROSTATIC NEOPLASMS;

EID: 0018831861     PISSN: 00071331     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.1980.tb08932.x     Document Type: Article

References (10)

1. Aminoglutethimide (Elipton‐Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial
2. Pharmacologic alteration of steroid hormone functions
3. Comparative trial of trans‐sphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer
4. Experience with 6‐aminoglutethimide in the treatment of metastatic breast cancer
5. Medical and surgical adrenalectomy in patients with advanced breast carcinoma
6. Adrenal suppression in the treatment of carcinoma of the prostate
7. The effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma
8. Aminoglutethimide medical adrenalectomy for advanced prostatic carcinoma
9. Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer
10. Medical adrenalectomy with aminoglutethimide: clinical study on post‐menopausal patients with metastatic breast carcinoma